EPAS1 and paraganglioma: RET and VHL are HSP90 clients [22], and it has been reported that the expression of HIF-1α and HIF-2α (an HSP90 client) were implicated in the pathogenesis of paraganglioma with SDHB and SDHD mutations [23].